Immuneering (IMRX) Accumulated Depreciation (2020 - 2022)

Immuneering (IMRX) posted quarterly Accumulated Depreciation of $418337.0 for Q4 2022, up 140.12% year-over-year from $174219.0 in Q4 2021, and up 21.41% quarter-over-quarter from $344556.0 in Q3 2022.

Immuneering (IMRX) Accumulated Depreciation (2020 - 2022) Analysis & Trends

Immuneering's Accumulated Depreciation history runs 3 years deep, the most recent figure standing at $418337.0 for Q4 2022.

  • In Q4 2022, Accumulated Depreciation rose 140.12% year-over-year to $418337.0; the TTM figure through Dec 2022 stood at $418337.0 (up 140.12% YoY), while the FY2022 annual figure was $418337.0, up 140.12% from the prior year.
  • Accumulated Depreciation for Q4 2022 stood at $418337.0, up from $344556.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation was $418337.0 in Q4 2022, with the low at $128752.0 in Q4 2020.
  • The 3-year median for Accumulated Depreciation is $198071.0 (2021), against an average of $233887.4.
  • The sharpest annual moves came in 2021 and 2022: Accumulated Depreciation jumped 35.31% in 2021, then surged 140.12% in 2022.
  • Immuneering's Accumulated Depreciation stood at $128752.0 in 2020, then surged by 35.31% to $174219.0 in 2021, then soared by 140.12% to $418337.0 in 2022.
  • Business Quant data shows IMRX's Accumulated Depreciation at $418337.0 in Q4 2022, $344556.0 in Q3 2022, and $276482.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Immuneering 327.37 Mn 327.37 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 418,337.00
Sep 30, 2022 344,556.00
Jun 30, 2022 276,482.00
Mar 31, 2022 221,923.00
Dec 31, 2021 174,219.00
Sep 30, 2021 159,404.00
Jun 30, 2021 147,426.00
Dec 31, 2020 128,752.00